mission & vision
No need is too small and no voice is too quiet to be heard. We will devote the time and energy necessary to educate, advocate and feed.
Prodrin Caplets currently have a 'patent pending' status. The patent filing is based on the use of isometheptene, acetaminophen, and caffeine in a solid dosage formulation, intending to treat the symptoms of migraines, tension, and cluster headaches. Estimated patent response is December 2014.